Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Fox Business | Business News & Stock Quotes - Saving & Investin…
February 8, 2026
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Discussion in the ATmosphere